Skip to main navigation Skip to search Skip to main content

NCOG-40. UTILITY OF THE SEIZURE CONTROL COMPOSITE INDEX (RANO-SCCI) IN EVALUATING SEIZURES IN CNS TUMOR PATIENTS

  • Hope Miller
  • , Alexa Christ
  • , Ewa Grajkowska
  • , Alvina Acquaye
  • , Kendra Adegbesan
  • , Lisa Boris
  • , Eric Burton
  • , Claudia Chambers
  • , Anna Choi
  • , Karen Evans
  • , Amanda King
  • , Edina Komlodi-Pasztor
  • , Heather Leeper
  • , Jason Levine
  • , Matthew Lindsley
  • , Nicole Lollo
  • , Kelly Mentges
  • , Marissa Panzer
  • , Marta Penas-Prado
  • , Valentina Pillai
  • Lily Polskin, Jennifer Reyes, Kayla Roche, James Rogers, Solmaz Sahebjam, Dilorom (Delia) Sass, Dorela Shuboni-Mulligan, Macy Stockdill, Brett Theeler, Kathleen Wall, Alex Wollet, Jing Wu, Jose Diarte, Mark Gilbert, Edward Avila, Terri Armstrong, Elizabeth Vera

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
Pages (from-to)vii206-vii206
JournalNeuro-Oncology
Volume24
Issue numberSupplement_7
DOIs
StatePublished - Dec 2022

Fingerprint

Dive into the research topics of 'NCOG-40. UTILITY OF THE SEIZURE CONTROL COMPOSITE INDEX (RANO-SCCI) IN EVALUATING SEIZURES IN CNS TUMOR PATIENTS'. Together they form a unique fingerprint.

Cite this